ストックスクリーナーアプリを入手
58.53
3.94%
2.22
アフターアワーズ：
58.09
-0.44
-0.75%
前日終値:
$56.31
開ける：
$56.67
24時間の取引高:
3.60M
Relative Volume:
1.00
時価総額：
$25.94B
収益：
$2.44B
当期純損益:
$1.36B
株価収益率:
30.66
EPS:
1.9093
ネットキャッシュフロー:
$574.14M
1週間 パフォーマンス:
+0.98%
1か月 パフォーマンス:
+7.97%
6か月 パフォーマンス:
+47.99%
1年 パフォーマンス:
+64.41%
1日の値動き範囲:
$56.45
$58.60
1週間の範囲:
$54.95
$58.60
52週間の値動き範囲:
$34.08
$58.84
Royalty Pharma Plc Stock (RPRX) Company Profile
名前
Royalty Pharma Plc
セクター
電話
(212) 883-0200
住所
110 EAST 59TH STREET, NEW YORK, NY
Compare RPRX vs VRTX, REGN, ARGX, RVMD, ALNY
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
58.53 | 24.96B | 2.44B | 1.36B | 574.14M | 1.9093 |
VRTX
Vertex Pharmaceuticals Inc
|
486.03 | 121.09B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
678.94 | 69.66B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
857.97 | 53.99B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
179.18 | 39.21B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
283.15 | 37.27B | 4.29B | 577.22M | 641.34M | 4.2086 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-30 | アップグレード | UBS | Neutral → Buy |
| 2025-09-30 | 開始されました | Goldman | Buy |
| 2025-05-16 | 開始されました | Morgan Stanley | Overweight |
| 2024-06-03 | ダウングレード | UBS | Buy → Neutral |
| 2022-06-14 | 再開されました | UBS | Buy |
| 2022-05-13 | 開始されました | Scotiabank | Sector Outperform |
| 2022-04-27 | 開始されました | Goldman | Buy |
| 2022-04-14 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-04-06 | 再開されました | Morgan Stanley | Overweight |
| 2021-10-29 | アップグレード | Citigroup | Neutral → Buy |
| 2021-07-30 | 開始されました | Tigress Financial | Buy |
| 2020-11-09 | アップグレード | UBS | Neutral → Buy |
| 2020-07-14 | 開始されました | Evercore ISI | In-line |
| 2020-07-13 | 開始されました | BofA Securities | Buy |
| 2020-07-13 | 開始されました | Citigroup | Neutral |
| 2020-07-13 | 開始されました | Cowen | Outperform |
| 2020-07-13 | 開始されました | Goldman | Neutral |
| 2020-07-13 | 開始されました | JP Morgan | Neutral |
| 2020-07-13 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-07-13 | 開始されました | SunTrust | Buy |
| 2020-07-13 | 開始されました | UBS | Neutral |
すべてを表示
Royalty Pharma Plc (RPRX) 最新ニュース
RPHC5824522 Bond Coupon Profile — Rate & Payments - TradingView
Royalty Pharma to announce Q2 2026 financial results on August 5 - scanx.trade
Royalty Pharma schedules 8 a.m. webcast for Aug. 5 results - Stock Titan
US78081BAN3 Bond Coupon Profile — Rate & Payments - TradingView
US78081BAN3 Bond Risk Profile - TradingView
Royalty Pharma PLC $RPRX Shares Sold by J. Safra Sarasin Holding AG - MarketBeat
Calamos Advisors LLC Takes Position in Royalty Pharma PLC $RPRX - MarketBeat
RPHC5824522 Bond Risk Profile - TradingView
RPHC5824522 Bond Profile — Key Metrics - TradingView
Calamos Wealth Management LLC Acquires New Shares in Royalty Pharma PLC $RPRX - MarketBeat
US78081BAQ6 Bond Coupon Profile — Rate & Payments - TradingView
Canal Insurance CO Acquires Shares of 20,000 Royalty Pharma PLC $RPRX - MarketBeat
RPHC5237891 Bond Profile — Key Metrics - TradingView
RPHC5237891 Bond Coupon Profile — Rate & Payments - TradingView
RPHC5237891 Bond Risk Profile - TradingView
US78081BAQ6 Bond Risk Profile - TradingView
US78081BAQ6 Bond Profile — Key Metrics - TradingView
Royalty Pharma (RPRX) Stock Analysis: A Strategic Look At Growth And Valuation Potential - DirectorsTalk Interviews
Royalty Pharma Q1 2026 earnings preview - MSN
World Investment Advisors Sells 48,485 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX is Torray Investment Partners LLC's Largest Position - MarketBeat
Hsbc Holdings PLC Lowers Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (RPRX) Morgan Stanley’s 22nd Annual Global Healthcare Conference summary - Quartr
Royalty Pharma (RPRX) Citi Annual Global Healthcare Conference 2025 Summary - Quartr
Why Royalty Pharma (RPRX) Could Beat Earnings Estimates Again - Yahoo! Finance Canada
Are You Looking for a Top Momentum Pick? Why Royalty Pharma (RPRX) is a Great Choice - Yahoo! Finance Canada
Royalty Pharma PLC (RPRX) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Russell 1000 Defensive Inclusion Might Change The Case For Investing In Royalty Pharma (RPRX) - Sahm
How (RPRX) Movements Inform Risk Allocation Models - Stock Traders Daily
RPRX or ACAD: Which Is the Better Value Stock Right Now? - Yahoo Finance
Teva Reports Early Skin Repigmentation Data, Sets Stage For Next Trial - Sahm
Royalty Pharma (RPRX) Could Be 2% Undervalued On Russell 1000 Defensive Index Addition - Sahm
Y Intercept Hong Kong Ltd Grows Stake in Royalty Pharma PLC $RPRX - MarketBeat
Swedbank AB Sells 355,450 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma stock hits all-time high at 58.02 USD By Investing.com - Investing.com South Africa
Royalty Pharma stock hits all-time high at 58.02 USD - Investing.com
Royalty Pharma plc (RPRX) Stock Analysis: Navigating the Biotech Sector with Robust Revenue Growth - DirectorsTalk Interviews
Royalty Pharma PLC $RPRX Shares Sold by Inspire Investing LLC - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Boosts Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Fideuram Intesa Sanpaolo Private Banking S.P.A. Has $439,000 Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC (NASDAQ:RPRX) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Moran Wealth Management LLC Boosts Stock Position in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC (RPRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ETFs Investing in Royalty Pharma Plc Class A Stocks - TradingView
USS Investment Management Ltd Boosts Position in Royalty Pharma PLC $RPRX - MarketBeat
Pictet Asset Management Holding SA Increases Stake in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (NASDAQ:RPRX) EVP Sells $5,652,000.00 in Stock - MarketBeat
[Form 4] Royalty Pharma plc Insider Trading Activity - Stock Titan
Royalty Pharma (RPRX) EVP Hite sells 130,000 shares in 10b5-1 trades - Stock Titan
Insider Selling: Royalty Pharma (NASDAQ:RPRX) EVP Sells 9,099 Shares - MarketBeat
Royalty Pharma plc (RPRX) insider Marshall Urist reports sales totaling ~$1.95M - Stock Titan
Royalty Pharma Plc (RPRX) 財務データ
収益
当期純利益
現金流量
EPS
7.51%
1.36%
大文字化:
|
ボリューム (24 時間):